Co-Diagnostics, Inc. Announces Resignation of Brent Satterfield as Director
April 30, 2019 at 03:13 pm
Share
On April 24, 2019, Co-Diagnostics, Inc. announced that its director, Brent Satterfield resigned. Mr. Satterfield had served as a member of Board since the formation of the company in 2013 and remains associated with the company as Chief Science Officer. This resignation is not the result of any disagreement with the company on any matter related to the company’s operations, policies, or practices.
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Companyâs technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the userâs mobile device.
CO-DIAGNOSTICS, INC. 
